Evidence map›Paper›PMID 41860964›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Quantifying the fidelity of in vitro human cell culture systems using a biomedical foundation model.

Satoru Fujii, Scott T Espenschied, Vibha Anand, Joao Bettencourt-Silva, Yi Han, Go Ito, Akira Koseki, Akihiro Kosugi, James Kozloski, Ryoma Matsumoto and 12 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Quantifying the fidelity of in vitro human cell culture systems using a biomedical foundation model.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Satoru Fujii *Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.
Scott T Espenschied *Department of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0001-8885-7532
Vibha AnandHealthcare and Life Sciences, International Business Machines Corporation Research, Yorktown Heights, NY 10598.ORCID 0000-0001-8605-5712
Joao Bettencourt-SilvaHealthcare and Life Sciences, International Business Machines Corporation Research, Dublin 2 D02 F6N2, Ireland.ORCID 0000-0002-4562-0911
Yi HanDepartment of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.
Go ItoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.
Akira KosekiHealthcare and Life Sciences, International Business Machines Corporation Research, Tokyo 103-8510, Japan.
Akihiro KosugiHealthcare and Life Sciences, International Business Machines Corporation Research, Tokyo 103-8510, Japan.
James KozloskiHealthcare and Life Sciences, International Business Machines Corporation Research, Yorktown Heights, NY 10598.ORCID 0000-0003-3420-4688
Ryoma MatsumotoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.
Shanshan MengDepartment of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.
Natasha MulliganHealthcare and Life Sciences, International Business Machines Corporation Research, Dublin 2 D02 F6N2, Ireland.ORCID 0009-0006-5631-0325
Ryan J MusichDepartment of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0003-4272-1036
Kevin P NewhallDepartment of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0002-4226-718X
Eri OshinaDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.
Shuhei SekiguchiDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.ORCID 0000-0001-5984-1064
Yi WangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Jianying HuHealthcare and Life Sciences, International Business Machines Corporation Research, Yorktown Heights, NY 10598.
Matthew CiorbaDivision of Gastroenterology and the Inflammatory Bowel Diseases Center, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-7656-0982
L David SibleyDeparment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0001-7110-0285
Ryuichi OkamotoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo 113-8510, Japan.ORCID 0000-0002-7047-571X
Thaddeus S StappenbeckDepartment of Inflammation and Immunity, Cleveland Clinic Research, The Cleveland Clinic, Cleveland, OH 44195.ORCID 0000-0002-6023-3901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cell culture is fast becoming a dominant method for discovery work regarding human disease. Currently, there are no methods to quantitatively benchmark these systems. Here, we apply a uniform in vitro culture system of human intestinal epithelial cells (IECs) to achieve this goal. We previously established methods for long-term two-dimensional (2D) cultivation of mouse IECs using an air-liquid interface (ALI) technique. Here, we further refined these methods for long-term 2D cultivation of human IECs, with histological and molecular features of differentiated intestinal epithelia. Leveraging the power and scalability of a biomedical foundation model (BMFM) trained on single-cell RNA sequencing data (BMFM-RNA), we performed classification tasks to identify cell types across sample sources and to quantitatively benchmark our in vitro differentiated cells against cells collected from patient biopsies. We observed a striking concordance between our in vitro differentiated cells and the corresponding cell types in vivo for multiple differentiated secretory cell types. This approach using BMFM-RNA holds promise to expand our understanding of the regulatory mechanisms, including gene-gene regulation underlying homeostasis and regeneration, as well as the functions of rare and poorly understood lineages within the human intestinal epithelia. Moreover, these methods may be applicable to other organs, model systems, and experimental modalities. We propose that the framework used here can be deployed as a standard benchmarking methodology, ultimately improving the fidelity of primary human culture systems.

Indexed as

Cell Culture TechniquesEpithelial CellsIntestinal MucosaAnimalsCell DifferentiationHumansMiceModels, Biologicalbiomedical foundation modelsepithelial cellsintestinesingle cell RNAseq

Identifiers

PMID41860964
PMCPMC13012098

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.